{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:12:30Z","timestamp":1767906750518,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.autrev.2011.05.008","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T17:11:51Z","timestamp":1306084311000},"page":"167-173","source":"Crossref","is-referenced-by-count":93,"title":["Immune-mediated CNS diseases: A review on nosological classification and clinical features"],"prefix":"10.1016","volume":"11","author":[{"given":"Uwe K.","family":"Zettl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"St\u00fcve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Patejdl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.05.008_bb0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.56.10.1257","article-title":"ADEM: distinct disease or part of the MS spectrum?","volume":"56","author":"Hartung","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2009.05.017","article-title":"The clinical spectrum of the neurological involvement in vasculitides","volume":"285","author":"Rossi","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2011.05.008_bb0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1212\/WNL.48.3.572","volume":"48","author":"Lublin","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0030","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0035","series-title":"Multiple sclerosis and cerebrospinal fluid","year":"2005"},{"key":"10.1016\/j.autrev.2011.05.008_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/WCO.0b013e32832b5417","article-title":"Multiple sclerosis and the major histocompatibility complex","volume":"22","author":"Ramagopalan","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0045","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198612253152603","article-title":"A population-based study of multiple sclerosis in twins","volume":"315","author":"Ebers","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.05.008_bb0050","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.008_bb0055","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0b013e3181b8a9f8","article-title":"Transcranial brain sonography findings predict disease progression in multiple sclerosis","volume":"73","author":"Walter","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0065","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis","volume":"129","author":"DeLuca","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.008_bb0070","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2353\/ajpath.2009.090340","article-title":"Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss","volume":"175","author":"Sobottka","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.05.008_bb0095","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","article-title":"Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations","volume":"255","author":"Wiendl","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0100","first-page":"150","article-title":"Escalating immunomodulatory therapy of multiple sclerosis","volume":"72","year":"2001","journal-title":"Der Nervenarzt"},{"key":"10.1016\/j.autrev.2011.05.008_bb0105","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nurt.2007.08.003","article-title":"Immunosuppressive agents in multiple sclerosis","volume":"4","author":"Neuhaus","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.autrev.2011.05.008_bb0110","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.05.008_bb0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.05.008_bb0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon \u03b2-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.05.008_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon \u03b2-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.05.008_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/pgs.09.152","article-title":"Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-\u03b2-1b treatment in relapsing remitting MS","volume":"11","author":"Goertsches","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.autrev.2011.05.008_bb0135","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/01.wnl.0000277703.74115.d2","article-title":"Interferon-\u03b2: mechanism of action and dosing issues","volume":"68","author":"Markowitz","year":"2007","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.05.008_bb0140","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1212\/WNL.0b013e3181c97e39","article-title":"The mechanism of action of glatiramer acetate treatment in multiple sclerosis","volume":"74","author":"Racke","year":"2010","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1016\/j.autrev.2011.05.008_bb0145","doi-asserted-by":"crossref","first-page":"V50","DOI":"10.1007\/s00415-006-5007-x","article-title":"Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis","volume":"253","author":"Dudesek","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/092986710790416245","article-title":"Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis","volume":"17","author":"Trebst","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2011.05.008_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri2761","article-title":"Therapeutic antibodies for autoimmunity and inflammation","volume":"10","author":"Chan","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/1352458502ms785rr","article-title":"The pathology of primary progressive multiple sclerosis","volume":"8","author":"Br\u00fcck","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2011.05.008_bb0165","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s00415-010-5614-4","article-title":"Intrathecal methotrexate treatment in multiple sclerosis","volume":"257","author":"Sadiq","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0170","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00415-010-5601-9","article-title":"The radiologically isolated syndrome: take action when the unexpected is uncovered?","volume":"257","author":"Sellner","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0175","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/14656561003677390","article-title":"Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group","volume":"11","author":"Doggrell","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.autrev.2011.05.008_bb0180","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0190","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1136\/bjo.2009.159350","article-title":"Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy","volume":"93","author":"Frohman","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.008_bb0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.lpm.2009.06.022","article-title":"Devic's neuromyelitis optica and related neurological disorders","volume":"39","author":"Marignier","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2011.05.008_bb0205","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458504ms988oa","article-title":"Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations","volume":"10","author":"Bergamaschi","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2011.05.008_bb0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2011.05.008_bb0220","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0225","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","article-title":"Neuromyelitis optica and Asian phenotype of multiple sclerosis","volume":"1142","author":"Kira","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2011.05.008_bb0235","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","article-title":"Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients","volume":"59","author":"Tenembaum","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0240","first-page":"857","article-title":"A case of acute disseminated encephalomyelitis (ADEM) associated with demyelinating peripheral neuropathy","volume":"48","author":"Aimoto","year":"1996","journal-title":"No To Shinkei"},{"key":"10.1016\/j.autrev.2011.05.008_bb0245","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.inf.0000133048.75452.dd","article-title":"Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features","volume":"23","author":"Leake","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2011.05.008_bb0250","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.008_bb0255","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1084\/jem.184.6.2371","article-title":"Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease","volume":"184","author":"Evans","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.05.008_bb0260","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI27372","article-title":"\u201cViral d\u00e9j\u00e0 vu\u201d elicits organ-specific immune disease independent of reactivity to self","volume":"116","author":"Merkler","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.05.008_bb0265","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WCO.0b013e32833925ec","article-title":"Update on investigation and management of postinfectious encephalitis","volume":"23","author":"Sonneville","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0270","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/awg233","article-title":"Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain\u2013Barr\u00e9 syndrome","volume":"126","author":"Odaka","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.008_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0035-3787(06)74994-3","article-title":"Borderlines types of multiple sclerosis","volume":"162","author":"De Seze","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.autrev.2011.05.008_bb0280","first-page":"211","article-title":"Die sogenannte \u201cAkute Multiple Sklerose\u201d","volume":"27","author":"Marburg","year":"1906","journal-title":"J Psychiatr Neurol"},{"issue":"Suppl 4","key":"10.1016\/j.autrev.2011.05.008_bb0285","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1007\/s10072-004-0341-1","article-title":"Marburg type and Bal\u00f2's concentric sclerosis: rare and acute variants of multiple sclerosis","volume":"25","author":"Capello","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2011.05.008_bb0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410400106","article-title":"Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein","volume":"40","author":"Wood","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.008_bb0295","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archneurpsyc.1928.02210080044002","article-title":"Encephalitis periaxialis concentrica","volume":"19","author":"Bal\u00f3","year":"1928","journal-title":"Arch Neurol Psychiat"},{"key":"10.1016\/j.autrev.2011.05.008_bb0300","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awh457","article-title":"Tissue preconditioning may explain concentric lesions in Bal\u00f3's type of multiple sclerosis","volume":"128","author":"Stadelmann","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.008_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02901445","article-title":"Zur Kenntnis der sogenannten diffusen Hirnsklerose","volume":"10","author":"Schilder","year":"1912","journal-title":"Z Ges Neurol Psychiat"},{"key":"10.1016\/j.autrev.2011.05.008_bb0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10072-009-0113-z","article-title":"Schilder's disease: non-invasive diagnosis? A case report and review","volume":"30","author":"Bacigaluppi","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2011.05.008_bb0315","first-page":"107","article-title":"Schilder's myelinoclastic diffuse sclerosis","volume":"77","author":"Poser","year":"1986","journal-title":"Pediatrics"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T16:23:09Z","timestamp":1543767789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1568997211001108"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.05.008","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}